Peptide record

TPDB10657

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
25 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10657
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept APD_complete APD_hemolytic HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 25-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FFGWLIRGAIHAGKAIHGLIHRRRH
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C136H211N47O26
NDCEQMPSTYV
RGHI
2920.47
12.88
9
0
12
+5
1.47
-0.024
105.60
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
5500
1.88
0
Residue Composition
number
3
A
4
R
0
N
0
D
0
C
0
E
0
Q
4
G
4
H
4
I
2
L
1
K
0
M
2
F
0
P
0
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 3 R: 4 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 4 H: 4 I: 4 L: 2 K: 1 M: 0 F: 2 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
25 reviewed residue count
C136H211N47O26 sequence-only estimate (linear, free termini)
2920.47 sequence-only estimate (linear, free termini)
12.88 sequence-only estimate (linear, free termini)
+5 sequence-only estimate (linear, free termini)
1.47 sequence-only estimate (linear, free termini)
-0.024 sequence-only estimate (linear, free termini)
Evidence Records 17 records
Evidence 1 Activity

Activity

MIC
Antibacterial
1.5 µM

Target

S. iniae F-8502

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 5 uM), S. iniae F-8502 (MIC 1.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 1.25 uM), Vibriopenaeicida KHA (MIC 5 uM), V. harve
Evidence 2 Activity

Activity

MIC
Antibacterial
1.25 µM

Target

V. anguillarum ATCC 19264

Source & Reference

dbAMP DRAMP

Other

ainst Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 5 uM), S. iniae F-8502 (MIC 1.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 1.25 uM), Vibriopenaeicida KHA (MIC 5 uM), V. harveyi HUFP911 1 (ATCC 14126) (MIC 5 uM), V. vulnif
Evidence 3 Activity

Activity

MIC
Antibacterial
5 µM

Target

A. salmonicida NCMB 1102

Source & Reference

dbAMP DRAMP

Other

MIC 5 uM), V. vulnificus ET-7617(ATCC 33148) (MIC 2.5 uM), A-hydrophila ET-4 (MIC>40 uM), A. salmonicida NCMB 1102 (MIC 5 uM), P-putida ATCC 12633 (MIC >40 uM), and E-tarda ET-82016 (MIC>40 uM). Bactericidal activit
Evidence 4 Activity

Activity

MIC
Antifungal
1.5 µM

Target

S. iniae F-8502

Source & Reference

dbAMP DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 5 uM), S. iniae F-8502 (MIC 1.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 1.25 uM), Vibriopenaeicida KHA (MIC 5 uM), V. harve
Evidence 5 Activity

Activity

MIC
Antifungal
1.25 µM

Target

V. anguillarum ATCC 19264

Source & Reference

dbAMP DRAMP Antifungipept

Other

ainst Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 5 uM), S. iniae F-8502 (MIC 1.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 1.25 uM), Vibriopenaeicida KHA (MIC 5 uM), V. harveyi HUFP911 1 (ATCC 14126) (MIC 5 uM), V. vulnif
Evidence 6 Activity

Activity

MIC
Antifungal
5 µM

Target

A. salmonicida NCMB 1102

Source & Reference

dbAMP DRAMP Antifungipept

Other

MIC 5 uM), V. vulnificus ET-7617(ATCC 33148) (MIC 2.5 uM), A-hydrophila ET-4 (MIC>40 uM), A. salmonicida NCMB 1102 (MIC 5 uM), P-putida ATCC 12633 (MIC >40 uM), and E-tarda ET-82016 (MIC>40 uM). Bactericidal activit
Evidence 7 Activity

Activity

MIC
Antiparasitic
1.5 µM

Target

S. iniae F-8502

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 5 uM), S. iniae F-8502 (MIC 1.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 1.25 uM), Vibriopenaeicida KHA (MIC 5 uM), V. harve
Evidence 8 Activity

Activity

MIC
Antiparasitic
1.25 µM

Target

V. anguillarum ATCC 19264

Source & Reference

DRAMP

Other

ainst Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 5 uM), S. iniae F-8502 (MIC 1.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 1.25 uM), Vibriopenaeicida KHA (MIC 5 uM), V. harveyi HUFP911 1 (ATCC 14126) (MIC 5 uM), V. vulnif
Evidence 9 Activity

Activity

MIC
Antiparasitic
5 µM

Target

A. salmonicida NCMB 1102

Source & Reference

DRAMP

Other

MIC 5 uM), V. vulnificus ET-7617(ATCC 33148) (MIC 2.5 uM), A-hydrophila ET-4 (MIC>40 uM), A. salmonicida NCMB 1102 (MIC 5 uM), P-putida ATCC 12633 (MIC >40 uM), and E-tarda ET-82016 (MIC>40 uM). Bactericidal activit
Evidence 10 Activity

Activity

MIC
Antiviral
1.5 µM

Target

S. iniae F-8502

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 5 uM), S. iniae F-8502 (MIC 1.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 1.25 uM), Vibriopenaeicida KHA (MIC 5 uM), V. harve
Evidence 11 Activity

Activity

MIC
Antiviral
1.25 µM

Target

V. anguillarum ATCC 19264

Source & Reference

DRAMP

Other

ainst Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 5 uM), S. iniae F-8502 (MIC 1.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 1.25 uM), Vibriopenaeicida KHA (MIC 5 uM), V. harveyi HUFP911 1 (ATCC 14126) (MIC 5 uM), V. vulnif
Evidence 12 Activity

Activity

MIC
Antiviral
5 µM

Target

A. salmonicida NCMB 1102

Source & Reference

DRAMP

Other

MIC 5 uM), V. vulnificus ET-7617(ATCC 33148) (MIC 2.5 uM), A-hydrophila ET-4 (MIC>40 uM), A. salmonicida NCMB 1102 (MIC 5 uM), P-putida ATCC 12633 (MIC >40 uM), and E-tarda ET-82016 (MIC>40 uM). Bactericidal activit
Evidence 13 Activity

Activity

% Hemolysis
Hemolysis
10 70 %
[Ref.12581207]10% hemolytic activity at 0.25 µM, 70% hemolytic activity at 1 µM against human erythrocytes

Target

human erythrocytes

Source & Reference

Hemolytik APD_complete APD_hemolytic PD_Hemolysis
DRAMP4
Eur J Biochem. 2003 Feb 270(4):675-686.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 14 Activity

Activity

50% Hemolysis
Toxicity
1 µM
Hemolytic Cytotoxic
50% Hemolysis | 1 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major. | Eur J Biochem | 2003
Evidence 15 Activity

Activity

100% Hemolysis
Toxicity
10 µM
Hemolytic Cytotoxic
100% Hemolysis | 10 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major. | Eur J Biochem | 2003
Evidence 16 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.12581207]10% hemolytic activity at 0.25 µM, 70% hemolytic activity at 1 µM against human erythrocytes

Target

erythrocytes

Source & Reference

NA
DRAMP
Eur J Biochem. 2003 Feb 270(4):675-686.
Evidence 17 Hemolysis

Activity

10 70 %
% Hemolysis
[Ref.12581207]10% hemolytic activity at 0.25 µM, 70% hemolytic activity at 1 µM against human erythrocytes
Hemolysis

Target

human erythrocytes

Source & Reference

APD_complete APD_hemolytic HemoPI PD_Hemolysis
Eur J Biochem. 2003 Feb 270(4):675-686.
DRAMP4
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.